tm logo
LINQURE
Live/Registered
REGISTERED

on 07 May 2024

Last Applicant/ Owned by

Paasheuvelweg 25

Amsterdam

NL

1105BP

Serial Number

90736220 filed on 26th May 2021

Registration Number

7376828 registered on 07th May 2024

in the Principal Register

Correspondent Address

Julianne Abelman

Julianne Abelman Womble Bond Dickinson (US) LLP

New York, NY 10022

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

LINQURE

Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapy, gene therapy, cell therapy, gene diagnosis and gene testing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90736220

Mark Type

No Service Mark

Attorney Docket Number

No 880685

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th May 2024REGISTERED-PRINCIPAL REGISTER
27th Jan 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
26th Jan 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
25th Jan 2023ASSIGNED TO PETITION STAFF
12th Jan 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
18th Aug 2022EXTENSION OF TIME TO OPPOSE RECEIVED
20th Jul 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
20th Jul 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20th Jul 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED